Register For Our Mailing List

Register to receive our free weekly newsletter including editorials.

Home / 210

Third Link Growth Fund announces soft close

[Editor’s note: In September 2016, Chris Cuffe wrote to our readers with an update on the Third Link Growth Fund (the Fund). He said in part:

“I started Third Link in 2008 with a unique idea. What if I established a fund where all the fees received for managing the investments, net of some tiny expenses, were donated to charities. After a long career in wealth management, I felt I had an ability to select good fund managers who could outperform over time. If I could convince the managers and administrators to provide their services for free for a worthy cause, everyone could win.”

At the time, the Fund had recently exceeded $100 million, and Chris recommitted to close the fund to new investors when it reached $150 million. Since September 2016 there has been significant inflows to the Fund, to the great benefit of the many charities the Fund supports. Chris has this week issued a Media Release announcing that the Fund has almost reached this soft close target, and he has set a firm closure date. New investors will not be accepted after this date].


Third Link Growth Fund will be closed to new investors at the end of August 2017.

Launched in May 2008, the Fund invests in Australian equities via third party professional investment managers. Management fees are donated to charity.

Since its inception the Fund has donated more than $6.5 million to charity, predominantly those helping to support children and young people. It presently donates over $150,000 per month. This amount is expected to continue growing in future even with the Fund closed to new investors.

The Fund takes a portfolio approach to charitable giving, forging long-term partnerships with quality organisations such as Australian Indigenous Mentoring Experience (AIME), National Centre for Childhood Grief, The Song Room, batyr, Foundation for Rural and Regional Renewal, Dismantle, SHINE for Kids, BackTrack, Mirabel Foundation, Raise Foundation and Children’s Ground.

Chris Cuffe said, “I am extraordinarily proud of Third Link and the generosity of its pro bono fund managers and services providers that have made it possible. It was always my intention to close the Fund to new investors once it reached $150 million, and having exceeded $144 million at the end of June 2017, I have decided it is appropriate to close the Fund to new investors at the end of August 2017.”

The Fund commenced as a multi sector growth fund but, following investor feedback, altered its mandate in February 2012 when it became a purely Australian equities fund.

In the more than five and a half years since it has been an Australian equities fund, Third Link Growth Fund has produced a compound return of 14.0% per annum after fees, outperforming the S&P/ASX300 Accumulation Index by 3.1% per annum. This has demonstrated the success of its active management approach. Since inception over nine years ago, the Fund has delivered a compound return of 9.5% per annum after fees, despite the impact of the global financial crisis. During this same period, the bank bill rate was 3.6% per annum and the Australian share market returned 4.6% per annum.


Chris Cuffe is Founder and pro bono Portfolio Manager of Third Link Growth Fund.

The pro bono fund managers used in Third Link Growth Fund are Aberdeen Standard Investments (formerly Aberdeen Asset Management), Bennelong Australian Equity Partners, Colonial First State Global Asset Management, Cooper Investors, Greencape Capital, Harness Asset Management, JBWere Wealth Management, L1 Capital, Lazard Asset Management Pacific Co, Lennox Capital Partners, Montgomery Investment Management, Ophir Asset Management, Paradice Investment Management, and Pengana Capital.

The pro bono service providers to Third Link Growth Fund include Bennelong Funds Management (Responsible Entity), RBC Investor Services Trust (custodian and administrator), Minter Ellison (legal work), Deloitte (auditors and tax advisers to the Fund), Ernst & Young (auditors of the Manager) and Nexia Australia (tax advisers to the Manager).

If you would like to consider whether to invest in the Fund, please see the Product Disclosure Statement (PDS) and the Additional Information to the PDS here. The information above is general information only. It does not constitute financial, tax or legal advice or an offer or solicitation to subscribe for units in the Fund. There can be no assurance that the Fund will continue to achieve its targeted rate of return and no guarantee against loss resulting from an investment in the Fund.


Leave a Comment:


Most viewed in recent weeks

10 little-known pension traps prove the value of advice

Most people entering retirement do not see a financial adviser, mainly due to cost. It's a major problem because there are small mistakes a retiree can make which are expensive and avoidable if a few tips were known.

Check eligibility for the Commonwealth Seniors Health Card

Eligibility for the Commonwealth Seniors Health Card has no asset test and a relatively high income test. It's worth checking eligibility and the benefits of qualifying to save on the cost of medications.

Hamish Douglass on why the movie hasn’t ended yet

The focus is on Magellan for its investment performance and departure of the CEO, but Douglass says the pandemic, inflation, rising rates and Middle East tensions have not played out. Vindication is always long term.

Start the year right with the 2022 Retiree Checklist

This is our annual checklist of what retirees need to be aware of in 2022. It is a long list of 25 items and not everything will apply to your situation. Run your eye over the benefits and entitlements.

At 98-years-old, Charlie Munger still delivers the one-liners

The Warren Buffett/Charlie Munger partnership is the stuff of legends, but even Charlie admits it is coming to an end ("I'm nearly dead"). He is one of the few people in investing prepared to say what he thinks.

Should I pay off the mortgage or top up my superannuation?

Depending on personal circumstances, it may be time to rethink the bias to paying down housing debt over wealth accumulation in super. Do the sums and ask these four questions to plan for your future.

Latest Updates

Investment strategies

Three ways index investing masks extra risk

There are thousands of different indexes, and they are not all diversified and broadly-based. Watch for concentration risk in sectors and companies, and know the underlying assets in case liquidity is needed.

Investment strategies

Will 2022 be the year for quality companies?

It is easy to feel like an investing genius over the last 10 years, with most asset classes making wonderful gains. But if there's a setback, companies like Reece, ARB, Cochlear, REA Group and CSL will recover best.


2022 outlook: buy a raincoat but don't put it on yet

In the 11th year of a bull market, near the end of the cycle, some type of correction is likely. Underneath is solid, healthy and underpinned by strong earnings growth, but there's less room for mistakes.


Time to give up on gold?

In 2021, the gold price failed to sustain its strong rise since 2018, although it recovered after early losses. But where does gold sit in a world of inflation, rising rates and a competitor like Bitcoin?

Investment strategies

Global leaders reveal surprises of 2021, challenges for 2022

In a sentence or two, global experts across many fields are asked to summarise the biggest surprise of 2021, and enduring challenges into 2022. It's a short and sweet view of the changes we are all facing.


What were the big stockmarket listings in record 2021?

In 2021, sharemarket gains supported record levels of capital raisings and IPOs in Australia. The range of deals listed here shows the maturity of the local market in providing equity capital.


Let 'er rip: how high can debt-to-GDP ratios soar?

Governments and investors have been complacent about the build up of debt, but at some level, a ceiling exists. Are we near yet? Trouble is brewing, especially in the eurozone and emerging countries.



© 2022 Morningstar, Inc. All rights reserved.

The data, research and opinions provided here are for information purposes; are not an offer to buy or sell a security; and are not warranted to be correct, complete or accurate. Morningstar, its affiliates, and third-party content providers are not responsible for any investment decisions, damages or losses resulting from, or related to, the data and analyses or their use. Any general advice or ‘regulated financial advice’ under New Zealand law has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Ltd, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. For more information refer to our Financial Services Guide (AU) and Financial Advice Provider Disclosure Statement (NZ). You should consider the advice in light of these matters and if applicable, the relevant Product Disclosure Statement before making any decision to invest. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your situation, contact a professional financial adviser. Articles are current as at date of publication.
This website contains information and opinions provided by third parties. Inclusion of this information does not necessarily represent Morningstar’s positions, strategies or opinions and should not be considered an endorsement by Morningstar.

Website Development by Master Publisher.